Phaseoloidin
CAS No. 118555-82-1
Phaseoloidin( —— )
Catalog No. M20380 CAS No. 118555-82-1
Phaseoloidin a homogentisic acid glucoside from Nicotiana attenuata trichomes contributes to the plant's resistance against lepidopteran herbivores.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 34 | In Stock |
|
| 2MG | 30 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 70 | In Stock |
|
| 25MG | 113 | In Stock |
|
| 50MG | 164 | In Stock |
|
| 100MG | 248 | In Stock |
|
| 200MG | 356 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePhaseoloidin
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhaseoloidin a homogentisic acid glucoside from Nicotiana attenuata trichomes contributes to the plant's resistance against lepidopteran herbivores.
-
DescriptionPhaseoloidin a homogentisic acid glucoside from Nicotiana attenuata trichomes contributes to the plant's resistance against lepidopteran herbivores.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number118555-82-1
-
Formula Weight330.29
-
Molecular FormulaC14H18O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (302.76 mM)
-
SMILESOC[C@H]1O[C@@H](Oc2ccc(O)cc2CC(O)=O)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Maleimide
Maleimide (25-Pyrroledone) is a new nanoparticle surface functional group which favors easy conjugation with cell penetration peptides. The conjugation is enabled via click chemistry to preserve its biofunctions.
-
Pincainide
Pincainide is a novel beta-aminoaniline that inhibits, in a dose-dependent manner, diseases caused by abnormal norepinephrine vascular smooth muscle function.
-
RMC-6291
RMC-6291 is an orally active, covalent inhibitor of KRAS G12C (ON) that forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA), thereby preventing KRAS G12C (ON) from signaling via steric blockade of RAS effector binding and eliciting deep and durable suppression of RAS pathway activity in KRAS G12C tumor models .
Cart
sales@molnova.com